Yee Hui Yeo Profile
Yee Hui Yeo

@YeeHuiYeo1

Followers
469
Following
2K
Media
18
Statuses
381

Transplant hep, GI & IM @cedarssinai | Aspiring transplant hepatologist | AASLD Emerging Liver Scholar | Alcohol-liver and AI-liver

Los Angeles
Joined April 2022
Don't wanna be here? Send us removal request.
@BlaneyMD
Hanna Blaney, MD, MPH
13 days
I tell my patients with chronic liver disease (especially SLD ☂️) to eat like a body builder 💪, focusing on lean protein like🐟, chicken, Greek yougurt, beans, lentils. What’s good for the liver is good for head to toe health. Nutrition is 🔑 in SLD @AASLDtweets #TLM2025
0
6
60
@YeeHuiYeo1
Yee Hui Yeo
13 days
WEGOVY up up up it’s our doses You know together we’re slimming Gonna be, gonna be winning MASH hunting guys~~ #TLM2025 @AASLDtweets @AASLDFoundation @novonordisk
@AASLDtweets
AASLD
14 days
🚨 Now Online in @HEP_Journal: Updated #AASLD Practice Guidance on Semaglutide therapy for MASH. #hepatology #liverdisease #MASLD #TLM25 https://t.co/es1CNIiEvj
0
1
3
@YeeHuiYeo1
Yee Hui Yeo
14 days
Breaking: Psychiatric issues in ALD patients reduce treatment success & up relapse risks! Over the 10 yrs, certain psych conditions exploded in ALDs, but not all! Which ones? Why the surge? Fresh nationwide study drops JUST before #TLM2025 Check it out!
0
1
6
@ebtapper
Elliot Tapper
1 month
Many of our friends are in need - how can we help each other 1 in 4 hepatologists Report unhealthy alcohol use https://t.co/Qxri2LG0od
2
11
37
@juanpabloarab
Juan Pablo (JP) Arab, MD 
1 month
It’s here! 🎉The @AASLDtweets TLM mobile app is now available for download. Plan your meeting, personalize your schedule, and stay connected — anytime, anywhere. 📲 Download now:
1
3
18
@JSADJournal
Journal of Studies on Alcohol and Drugs
1 month
Randomized Controlled Trial Demonstrates Efficacy of a Culturally Adapted Behavioral Intervention Delivered in Spanish by Community Health Workers to Reduce Unhealthy Alcohol Use Among Latino/as (just accepted @JSADjournal) @AlisonMooreMD @UCSDMedSchool https://t.co/7xlEA2sEOI
0
2
3
@TheLancet
The Lancet
1 month
Alcohol use disorders consist of conditions characterised by compulsive heavy alcohol use and loss of control over alcohol intake. A new Seminar discusses the need for integrated alcohol control policies to improve the prevention of alcohol use disorders, improve access to
6
58
119
@EASLnews
EASLnews
1 month
🚨 Landmark in hepatology @JHepatology reports the world’s first pig-to-human liver xenotransplant in a living patient. A genetically engineered pig liver supported vital metabolic and synthetic functions in a 71-year-old man for 171 days. 👉 Proof-of-concept: genetically
1
16
24
@RajivJalan1
Prof Rajiv Jalan
2 months
Agree - the bedside description could be based on a modified PIRO Predisposition - aetiology, first / further Injury: precipitant Response: Infection - inflammation - biomarkers Organ: NAD / AD e.g. P: alcoholic cirrhosis - first I: infection R: inflammation O: NAD-Ascites
@ReibergerThomas
Thomas Reiberger
2 months
@drnipunverma @EASLnews @INASL_Liver @APASLnews @BASLedu @RajivJalan1 @BavenoCoop @ProfPaoloAngeli @RoyAHep @AnandVKulkarni2 @AASLDtweets @ef_clif @ajay_duseja @drsuniltaneja @SahajRathi From a clinical point of view - since pts are also seen outside the academic hepatology bubble - a staging system must be simple & therapeutically relevant. ⏩clear "bedside definitions" ⏩use readily available liver disease severity scales @EASLnews 2024 i presented this slide
0
4
7
@gman_dev
G-man. ⌨️
2 months
HOLY SH*T... Looking heavily into n8n and AI agents🤯 Built in n8n : 🧠 Generates raw ideas 📝 Refines script & video prompt 🎬 Creates video clips 🔊 Builds soundtrack 🧵 Stitches & renders final video 🚀 Posts to 9 platforms (TikTok, IG, YT, X…) 🔁 Like + Repost ✅ Reply
6
3
5
@YeeHuiYeo1
Yee Hui Yeo
2 months
Extremely honored and humbled! Grateful to my mentor @BrennanSpiegel @LiranOmer @ItaiDanovitch @JuDongYang1 Dr. Almario whose guidance and support made this possible. Looking forward to the career ahead!
@AASLDFoundation
AASLD Foundation
2 months
🌟 Join us in celebrating @YeeHuiYeo1 of @CedarsSinai for receiving the 2025 #AASLDFoundation Kimberly A. Brown Advanced/Transplant #Hepatology Fellow Award! #LiverTwitter
9
3
32
@AASLDFoundation
AASLD Foundation
3 months
👏 Big congratulations to these 2025 #AASLDFoundation #EmergingLiverScholars! 🌟Gurmehr Brar @KeckMedUSC 🌟Yueming Cao @YNHH 🌟@norinewchan @DukeMedSchool 🌟@sychan0514 @WeissHospital View the full list:: https://t.co/spYSpZhaBl
0
3
29
@VCU_Liver
VCU Stravitz-Sanyal Institute for Liver Disease
3 months
Join the Institute on Sept. 3 at noon for a research webinar by our director of alcohol sciences, @juanpabloarab, on "Alcohol-associated Liver Disease: From Bench to Public Health.” Register for the seminar at: https://t.co/YpdXOqsTpU
0
4
21
@JAMA_current
JAMA
3 months
Any daily #alcohol consumption is associated with certain cancers, and the risk of #cancer increases with higher alcohol intake. 📊 This JAMA Insights discusses the evidence related to the @Surgeon_General’s Advisory on alcohol and cancer risk. https://t.co/7iNaQIWYOb
3
88
229
@AliRezaieMD
Ali Rezaie MD MSc
4 months
When the “it’s all in your head” crowd wins, science loses, and patients get gaslit. Gut physiology is under attack: subtly, systematically and disguised as care.
@Nareshbhat14
Naresh bhat
4 months
How irrational can we get ? Who allows such combinations ?
1
3
17
@Gut_BMJ
Gut Journal
4 months
Read the excellent #GUTCommentary by Niu and Ding entitled "Alcohol exhibits contrasting effects on CD8+ T cells in the gut and liver in alcohol-associated liver disease" via https://t.co/d8IFtgPBsU #AlcoholicLiverDisease
0
5
12
@JWatch
NEJM Journal Watch
7 months
A new study should shift clinical practice for managing severe alcohol-associated hepatitis, writes Dr. Daniel Dressler. https://t.co/OC8xeLtCeA #hepatitis #MedTwitter @DresslerDD
1
15
39
@NIDAnews
NIDAnews
4 months
Medications for opioid use disorder (MOUD) are safe, effective, & save lives. FDA-approved treatments like methadone, buprenorphine, & naltrexone help reduce drug cravings, ease withdrawal, & lower overdose risk—but fewer than 1 in 5 people who need them receive them. (1/2)
5
5
11
@Richard_D_Riley
Richard Riley (R²)
5 months
*NEW OPEN-ACCESS PAPER* “A decomposition of Fisher’s information to inform sample size for developing or updating fair and precise clinical prediction models for individual risk—part 1: binary outcomes" - published in Diagnostic & Prognostic Research https://t.co/SKrhX5eUPp
2
8
43
@HepCommJournal
Hepatology Communications
5 months
🚨 Liver Biopsy remains a 🔑 tool in our 🧰 , so #GIHepFellowshipBootcamp is here to get you ready to understand: 💉Utility of biopsy across conditions❕ 💉Biopsy histologic characteristics❕ 💡The table below is GOLD 🏆 https://t.co/eUOMCGDjdN
1
71
160